Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.

Inflammatory bowel diseases - 1 Sept 2012

Al-Jarallah Khaled, Shehab Diaa, Al-Attiyah Rajaa, Al-Azmi Waleed, Al-Fadli Ahmad, Zafar Haider Mohammed, Panaccione Remo, Ghosh Subrata

Abstract excerpt

BACKGROUND: Antibodies that react with citrullinated proteins (anti-mutated citrullinated vimentin [anti-MCV] and second-generation anti-cyclic citrullinated peptide antibodies [anti-CCP2]) are markers for rheumatoid arthritis. Recent studies have demonstrated that these antibodies are present in other arthropathies including the spondyloarthritis, psoriatic arthritis, and juvenile idiopathic arthritis. Arthritis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Anti-Idiotypic
Share to Arthritis, Rheumatoid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Autoantibodies

Share to Biomarkers

Share to Citrulline

Share to Inflammatory Bowel Diseases

Share to Peptides, Cyclic

Share to Vimentin

Source

Identifiers

PMID: 22114016
DOI: 10.1002/ibd.21937

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis.PMID 22114016Read ↗

Antibodies to mutated citrullinated vimentin and antibodies to cyclic citrullinated peptides in juvenile idiopathic arthritis.Semantic proximity Read ↗

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy.Semantic proximity Read ↗

Antibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis.Semantic proximity Read ↗

Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.Semantic proximity Read ↗

Mutated citrullinated vimentin antibodies in rheumatoid arthritis.Semantic proximity Read ↗

Antibodies to citrullinated vimentin are a specific and sensitive marker for the diagnosis of rheumatoid arthritis.Semantic proximity Read ↗

Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris.Semantic proximity Read ↗

Antibody against mutated citrullinated vimentin: a new sensitive marker in the diagnosis of rheumatoid arthritis.Semantic proximity Read ↗

Antibodies to mutated citrullinated vimentin and disease activity score in early arthritis: a cohort study.Semantic proximity Read ↗

Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.Semantic proximity Read ↗

The relevance of citrullinated vimentin in the production of antibodies against citrullinated proteins and the pathogenesis of rheumatoid arthritisSemantic proximity Read ↗

Greater prevalence of seropositivity for anti-cyclic citrullinated peptide antibody in unaffected first-degree relatives in multicase rheumatoid arthritis-affected families.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.